BRIGHT GREEN CORP (BGXX) Stock News

NASDAQ:BGXX - US10920G1004 - Common Stock

0.1481 USD

-0.04 (-22.01%)

Last: 9/18/2024, 8:00:00 PM

0.155 USD

+0.01 (+4.66%)

After Hours: 9/18/2024, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BGXX Latest News, Press Relases and Analysis

All

Press Releases

6 months ago - By: Bright Green Corporation

Bright Green Corporation Announces the next steps for the completion of its restructuring plan

7 months ago - By: Bright Green Corporation

Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances

7 months ago - By: Benzinga - Mentions: JPM MJ BMMJ HITI ...

This Week In Cannabis: Paraguay Nears Adult-Use Sales, JPMorgan Hints At Banking And More On Earnings, NHL, Tyson, STIIIZY, Germany

7 months ago - By: Bright Green Corporation

Bright Green Corporation Has Signed Agreement with Majority Shareholder as Plan Sponsor on Prepackaged Plan to Restructure the Company.

a year ago - By: BusinessInsider

News Image

BGXX Stock Earnings: Bright Green Reported Results for Q2 2024

a year ago - By: InvestorPlace

BGXX Stock Earnings: Bright Green Reported Results for Q2 2024

a year ago - By: Bright Green Corporation

CEO UPDATE

9 months ago - By: Bright Green Corporation

LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT (“RSA”) WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.

a year ago - By: Benzinga

Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growth

a year ago - By: Bright Green Corporation

Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships

a year ago - By: Bright Green Corporation

BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.

a year ago - By: BusinessInsider

News Image

BGXX Stock Earnings: Bright Green Reported Results for Q1 2024

a year ago - By: InvestorPlace

BGXX Stock Earnings: Bright Green Reported Results for Q1 2024

a year ago - By: InvestorPlace

BGXX Stock Earnings: Bright Green Reported Results for Q4 2023

a year ago - By: Bright Green Corporation

BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.

a year ago - By: Bright Green Corporation

BRIGHT GREEN ANNOUNCES IT HAS OBTAINED A $3.5 MILLION FUNDING COMMITMENT UNDER AN EXISTING LINE OF CREDIT AND HAS ENGAGED AN INVESTMENT BANK TO SEEK A $15.0 MILLION DEBT FINANCING TO MOVE FORWARD WITH COMMERCIALIZATION.

1 years ago - By: Bright Green Corporation

BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.

1 years ago - By: Bright Green Corporation

BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING

2 years ago - By: Bright Green Corporation

Bright Green Corporation (BGXX) submits for historic DEA Registration for Production of Schedule I and Schedule II controlled substances.

2 years ago - By: Bright Green Corporation

BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS